It cites another study that "found that the odds ratio for finding results favorable to industry in industry-sponsored trials was 3.6 times as high as in non–industry-sponsored studies". Issues discussed regarding industry-sponsored studies include: comparison of a drug to a placebo, but not to an alternative treatment; unpublished studies with unfavorable outcomes; and trials organized around a placebo baseline followed by drug treatment, but not counterbalanced with parallel-placebo-controlled studies. Quoting a 1979 report that too little research into hypnotics was independent of the drug manufacturers, the authors conclude, "the public desperately needs an equipoised assessment of hypnotic benefits and risks" and the NIH and VA should provide leadership to that end. Street terms
Street terms for temazepam include king kong pills (formerly referred to barbiturates, now more commonly refers to temazepam), jellies, jelly, Edinburgh eccies, tams, terms, mazzies, temazies, tammies, temmies, beans, eggs, green eggs, wobbly eggs, knockouts, hardball, norries, oranges (common term in Australia and New Zealand), rugby balls, ruggers, terminators, red and blue, no-gos, num nums, blackout, green devils, drunk pills, brainwash, mind erasers, neurotrashers, tem-tems (combined with buprenorphine), mommys big helper, vitamin T, big T, TZ, the mazepam, resties (North America) and others. Availability
Temazepam is available in English-speaking countries under the following brand names:

Euhypnos
Normison
Norkotral
Nortem
Remestan
Restoril
Temaze
Temtabs
In Spain, the drug is sold as temzpem. In Hungary the drug is sold as Signopam. Legal status
In Austria, temazepam is listed in UN71 Schedule III under the Psychotropic Substances Decree of 1997.
However, no treatment was deemed well-established to treat any form of BFRBs. Pharmacotherapy
Excoriation disorder, and trichotillomania have been treated with inositol and N-acetylcysteine. Prevalence
BFRBs are among the most poorly understood, misdiagnosed, and undertreated groups of disorders. BFRBs may affect at least 1 out of 20 people. These collections of symptoms have been known for a number of years, but only recently have appeared in widespread medical literature. Trichotillomania alone is believed to affect 10 million people in the United States. See also
Stereotypic movement disorder
Rhythmic Movement Disorder
Body dysmorphic disorder
Habit reversal training
Decoupling treatment

References


== External links ==